Gerald Blumenstock Sells 1,015 Shares of Axcelis Technologies (NASDAQ:ACLS) Stock

Axcelis Technologies, Inc. (NASDAQ:ACLSGet Free Report) EVP Gerald Blumenstock sold 1,015 shares of the stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $162.31, for a total transaction of $164,744.65. Following the completion of the sale, the executive vice president owned 17,293 shares in the company, valued at $2,806,826.83. This represents a 5.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Axcelis Technologies Price Performance

Shares of ACLS stock traded down $6.46 during trading hours on Friday, hitting $155.18. The company’s stock had a trading volume of 556,297 shares, compared to its average volume of 788,623. The business has a fifty day moving average of $113.26 and a 200-day moving average of $95.52. The stock has a market cap of $4.77 billion, a price-to-earnings ratio of 48.34, a P/E/G ratio of 12.91 and a beta of 1.93. Axcelis Technologies, Inc. has a twelve month low of $55.93 and a twelve month high of $171.61. The company has a current ratio of 4.59, a quick ratio of 2.99 and a debt-to-equity ratio of 0.04.

Axcelis Technologies (NASDAQ:ACLSGet Free Report) last released its quarterly earnings results on Thursday, May 7th. The semiconductor company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.71 by $0.01. The business had revenue of $198.96 million for the quarter, compared to analyst estimates of $195.03 million. Axcelis Technologies had a net margin of 11.93% and a return on equity of 12.19%. The company’s quarterly revenue was up 3.3% on a year-over-year basis. During the same period in the prior year, the business earned $0.88 earnings per share. Axcelis Technologies has set its Q2 2026 guidance at 0.900- EPS. As a group, equities research analysts anticipate that Axcelis Technologies, Inc. will post 2.86 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. B. Riley Financial raised shares of Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 target price for the company in a research note on Monday, April 20th. Zacks Research raised shares of Axcelis Technologies from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. Finally, Weiss Ratings cut shares of Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Tuesday. Three research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $116.25.

Check Out Our Latest Stock Analysis on ACLS

Hedge Funds Weigh In On Axcelis Technologies

Hedge funds have recently made changes to their positions in the stock. REAP Financial Group LLC acquired a new position in shares of Axcelis Technologies in the 4th quarter valued at $25,000. Close Asset Management Ltd acquired a new position in shares of Axcelis Technologies in the 3rd quarter valued at $27,000. EverSource Wealth Advisors LLC boosted its holdings in shares of Axcelis Technologies by 145.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 451 shares of the semiconductor company’s stock valued at $31,000 after purchasing an additional 267 shares during the last quarter. Caitlin John LLC acquired a new position in shares of Axcelis Technologies in the 3rd quarter valued at $32,000. Finally, Advisory Services Network LLC acquired a new position in shares of Axcelis Technologies in the 3rd quarter valued at $32,000. Institutional investors and hedge funds own 89.98% of the company’s stock.

About Axcelis Technologies

(Get Free Report)

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.

Featured Articles

Insider Buying and Selling by Quarter for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.